WeVote
Log In

Bill

Bill

H 4332

An Act relative to pharmacists as healthcare providers

194th Legislature (2025-2026) Introduced by Christine Barber

Massachusetts bill recognizes pharmacists as healthcare providers, expanding their clinical service scope to improve medication safety and healthcare access while delegating appropriate tasks from physicians.

Reporting date extended to Friday, July 31, 2026
0
WeVote Research Nonpartisan
Bill Summary · H 4332

Legislative bill overview

H 4332 expands the scope of practice for pharmacists in Massachusetts by formally recognizing them as healthcare providers under state law. The bill enables pharmacists to perform expanded clinical services, potentially including medication therapy management, certain diagnostic testing, and other clinical functions within their professional competency. This represents a shift toward utilizing pharmacists' clinical expertise in the broader healthcare delivery system.

Why is this important

Pharmacists are often the most accessible healthcare professionals, and expanding their clinical role could improve medication safety, reduce unnecessary emergency department visits, and help address healthcare access gaps—particularly in underserved areas. This change could also reduce administrative burden on physicians by delegating appropriate medication-related tasks to qualified pharmacists, though it depends heavily on implementation details and reimbursement mechanisms.

Potential points of contention

  • Scope definition and patient safety: Unclear boundaries on which clinical services pharmacists can provide without physician oversight may create liability questions and concerns about patient safety if services exceed training or competency
  • Insurance reimbursement: Expansion of pharmacist services requires insurance coverage and reimbursement rates; disagreement may arise over who pays and whether this increases overall healthcare costs or provides savings
  • Professional turf concerns: Physicians and nurse practitioners may resist expansion of pharmacist authority, viewing it as competitive rather than complementary, particularly regarding revenue and patient relationships

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.